Differentiation-dependent up-regulation of p47phox gene transcription is associated with changes in PU.1 phosphorylation and increased binding affinity

Biochemical and Biophysical Research Communications

Volumn 305, Issue 1, 2003, Pages 193-202

  Marden, Chloe M ^a   Stefanidis, Dimitrios ^a,c   Cunninghame Graham, Deborah S ^a   Casimir, Colin M ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PHOSPHATASE; PHOSPHOSERINE ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN P47; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BONE MARROW CELL; CELL DIFFERENTIATION; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA FLANKING REGION; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; REPORTER GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

EID: 0038745563     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00727-7     Document Type: Article

References (26)

1. Simon M.C., Olson M., Scott E., Hack A., Su G., Singh H. Terminal myeloid gene expression and differentiation requires the transcription factor PU.1. Curr. Top. Microbiol. Immunol. 211:1996;113-119.
2. Fisher R.C., Scott E.W. Role of PU.1 in hematopoiesis. Stem Cells. 16:1998;25-37.
3. Clarke S., Gordon S. Myeloid-specific gene expression. J. Leukoc. Biol. 63:1998;153-168.
4. Klemsz M.J., McKercher S.R., Celada A., Van B.C., Maki R.A. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene [see comments]. Cell. 61:1990;113-124.
5. Li S.L., Valente A.J., Zhao S.J., Clark R.A. PU.1 is essential for p47(phox) promoter activity in myeloid cells. J. Biol. Chem. 272:1997;17802-17809.
6. Rodaway A.R., Teahan C.G., Casimir C.M., Segal A.W., Bentley D.L. Characterization of the 47-kilodalton autosomal chronic granulomatous disease protein: tissue-specific expression and transcriptional control by retinoic acid. Mol. Cell Biol. 10:1990;5388-5396.
7. Casimir C.M., Teahan C.G. Hellewell P.G., Williams T.J. Immunopharmacology of Neutrophils. 1994;27-54 Academic Press, London.
8. Gupta J.W., Kubin M., Hartman L., Cassatella M., Trinchieri G. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumor necrosis factor and γ-interferon. Cancer Res. 52:1992;2530-2537.
9. Eichbaum Q.G., Iyer R., Raveh D.P., Mathieu C., Ezekowitz R.A. Restriction of interferon γ responsiveness and basal expression of the myeloid human FcγR1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J. Exp. Med. 179:1994;1985-1996.
10. Skalnik D.G., Strauss E.C., Orkin S.H. CCAAT displacement protein as a repressor of the myelomonocytic-specific gp91-phox gene promoter. J. Biol. Chem. 266:1991;16736-16744.
11. Sherman P.A., Basta P.V., Heguy A., Wloch M.K., Roeder R.G., Ting J.P. The octamer motif is a B-lymphocyte-specific regulatory element of the HLA-DRα gene promoter. Proc. Natl. Acad. Sci. USA. 86:1989;6739-6743.
12. Levinsky R.J., Harvey B.A., Rodeck C.H., Soothill J.F. Phorbol myristate acetate stimulated NBT test: a simple method suitable for antenatal diagnosis of chronic granulomatous disease. Clin. Exp. Immunol. 54:1983;595-598.
13. Pahl H.L., Burn T.C., Tenen D.G. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. Exp. Hematol. 19:1991;1038-1041.
14. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
15. Garner M.M., Revzin A. A gel electrophoresis method for quantifying the binding of proteins to specific DNA regions: application to components of the Escherichia coli lactose operon regulatory system. Nucleic Acids Res. 9:1981;3047-3060.
16. Eklund E.A., Skalnik D.G. Characterization of a gp91-phox promoter element that is required for interferon γ-induced transcription. J. Biol. Chem. 270:1995;8267-8273.
17. Carey J.O., Posekany K.J., deVente J.E., Pettit G.R., Ways D.K. Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition. Blood. 87:1996;4316-4324.
18. Lodie T.A., Savedra R.J., Golenbock D.T., Van B.C., Maki R.A., Fenton M.J. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158:1997;1848-1856.
19. Ford A.M., Bennett C.A., Healy L.E., Towatari M., Greaves M.F., Enver T. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP α, -β, and -δ during granulocyte-lineage specification. Proc. Natl. Acad. Sci. USA. 93:1996;10838-10843.
20. Marecki S., Fenton M.J. PU.1/interferon regulatory factor interactions: mechanisms of transcriptional regulation. Cell Biochem. Biophys. 33:2000;127-148.
21. Iida H., Towatari M., Iida M., Tanimoto M., Kodera Y., Ford A.M., Saito H. Protein expression and constitutive phosphorylation of hematopoietic transcription factors PU.1 and C/EBPβ in acute myeloid leukemia blasts. Int. J. Hematol. 71:2000;153-158.
22. Kim J., Feldman R.A. Activated Fes protein tyrosine kinase induces terminal macrophage differentiation of myeloid progenitors (U937 cells) and activation of the transcription factor PU.1. Mol. Cell Biol. 22:2002;1903-1918.
23. Xue Y., Alford P., Shackelford R.E. Protein kinase C activation increases binding of transcription factor PU.1 in murine tissue macrophages. Biochem. Biophys. Res. Commun. 254:1999;211-214.
24. Li S.L., Schlegel W., Valente A.J., Clark R.A. Critical flanking sequences of PU.1 binding sites in myeloid-specific promoters. J. Biol. Chem. 274:1999;32453-32460.
25. Rieske P., Pongubala J.M. AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domain. J. Biol. Chem. 276:2001;8460-8468.
26. Pongubala J.M., Van B.C., Nagulapalli S., Klemsz M.J., McKercher S.R., Maki R.A., Atchison M.L. Effect of PU.1 phosphorylation on interaction with NF-EM5 and transcriptional activation. Science. 259:1993;1622-1625.